BREAKING
Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 5 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 7 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 8 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 19 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 20 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 23 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 day ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 1 day ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 1 day ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 5 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 7 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 8 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 19 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 20 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 23 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 day ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 1 day ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 1 day ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago
ADVERTISEMENT
AlphaGraphs

STZ Earnings: All you need to know about Constellation Brands’ Q2 2025 earnings results

Constellation Brands, Inc. (NYSE: STZ) reported its second quarter 2025 earnings results today. Net sales grew 3% year-over-year to $2.91 billion. Comparable sales growth was also 3%. Net loss attributable to CBI was $1.19 billion, or $6.59 per share, compared to net income of $690 million, or $3.74 per share, last year. Comparable EPS rose […]

October 3, 2024 1 min read

Constellation Brands, Inc. (NYSE: STZ) reported its second quarter 2025 earnings results today.

Net sales grew 3% year-over-year to $2.91 billion. Comparable sales growth was also 3%.

Net loss attributable to CBI was $1.19 billion, or $6.59 per share, compared to net income of $690 million, or $3.74 per share, last year. Comparable EPS rose 14% YoY to $4.32.

Revenue and earnings beat estimates.

For fiscal year 2025, the company expects net sales growth of 4-6%. On a reported basis, EPS is estimated to be $4.05-4.25 while on a comparable basis, it is expected to be $13.60-13.80.

ADVERTISEMENT

The stock was down over 1% in premarket hours on Thursday.

Prior performance

ADVERTISEMENT